Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | EW | GILD |
|---|
| Close | 92.01 | 170.68 |
| Market Cap | $53.6B | $213B |
| 1M | +6.59% | +14.51% |
| P/E (TTM) | 53.7 | — |
| Forward P/E | 31.0 | 22.0 |
| P/E 5-Yr Percentile | 100 | — |
| P/S | 8.3 | 7.0 |
| P/B | 5.1 | 17.9 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $1.7B | $8.3B |
| Revenue YoY | +13.6% | +6.8% |
| Gross Margin | 77.5% | 81.1% |
| Latest Quarter EPS | 0.42 | 1.94 |
| Avg Post-Earnings Move | ±3.9% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | 2 / 2 | — |
| Shareholder Yield | 2.25% | 2.57% |
| 90-Day Net Insider Buying | −$3.5M | −$15.9M |
EW · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
